Skip to content

Clinical trials

Phase 2 Breast Carcinoma In Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Carcinoma In Situ Phase: Phase 2 Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20025
20031
20043
20051
20064
20081
20091
20102
20111
20121
20133
20141
20152
20161
20171
20182
20202
20212
20221
20232
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated12
Recruiting6
Unknown status2
Active, not recruiting2
Withdrawn1
Enrolling by invitation1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic5
National Cancer Institute (NCI)5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Alliance for Clinical Trials in Oncology2
City of Hope Medical Center2
Dana-Farber Cancer Institute2
Jonsson Comprehensive Cancer Center2
Northwestern University2
Wake Forest University Health Sciences2
Auxilio Mutuo Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Carcinoma In Situ47
Breast Neoplasms33
Carcinoma, Intraductal, Noninfiltrating29
Carcinoma, Ductal, Breast3
Carcinoma, Lobular3
Hot Flashes2
Breast Neoplasms, Male1
Dyspareunia1
Fatigue1
Fibrocystic Breast Disease1

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.